Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phytoestrogen compositions and associated methods

a technology of phytoestrogen and composition, which is applied in the field of compositions and methods for the administration of phytoestrogen to women, can solve the problems of increasing the long-term incidence of certain life-threatening conditions, affecting the effect of phytoestrogen metabolism, and requiring consumption, so as to achieve the effect of reducing the production of the more favorable 2-hydroxyestrone metabolite and synergistically affecting the estrogen metabolism

Inactive Publication Date: 2015-01-01
NSE PROD INC
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides methods for controlling the formation of estrogen metabolites. Specifically, by coadministering a phytoestrogen compound and an indole compound, there is a synergistic increase in the production of the inactive estrogen metabolite 2-hydroxyestrone compared to either compound alone. This leads to a shift in estrogen metabolism and a more favorable outcome. An estrogen metabolite controlling composition is also provided, which includes an effective amount of both an indole compound and a phytoestrogen compound.

Problems solved by technology

Many women have a difficult time managing the effects of hormonal changes that accompany the aging body.
It is now known that some estrogen therapies, despite their immediate benefits, may increase the long term incidences of certain life threatening conditions, such as cancer.
However, most phytoestrogens are less potent than traditional estrogens and need to be consumed in large quantities in order to have a significant estrogenic effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0047]In one embodiment, soft gel capsules may be used as a formulation for use in the present invention. Table 1 illustrates one embodiment of a soft gel formulation.

TABLE 1IngredientsDosage (mg / day)Borage Seed Oil, 17-25% GLA250Evening Primrose Oil 8-14% GLA500Indole-3-carbinol100Chasteberry PE 0.5%250Pomegranate extract40Lignans from Flaxseed (Linulife)15Genistein from soy isoflavones10

[0048]As a general matter, soft gel capsules are prepared by mixing glycerin, gelatin, carob and polysorbate together with water in a gelatin melter. Color is also added in the mixing stage. The melted gelatin mixture is placed in an encapsulation unit. The melted gelatin mixture solidifies to obtain a gelatin ribbon. The gelatin ribbon is filled and sealed with the formulation inside. The filled gelatin ribbon is cut and formed into soft gelatin capsules. Finally, the soft gelatin capsules are tumbled dried.

example 2

[0049]Dry powder formulations in accordance with two embodiments of the present invention are prepared to include ingredients and amounts as recited in Tables 2 & 3.

TABLE 2IngredientsDosage (mg / day)Black Cohosh Extract (2.5% triterpenes)40Pomegranate Extract40Lignans from Flaxseed (Linulife)20Genistein from soy isoflavones15Indole-3-carbinol100Broccoli Powder200

TABLE 3IngredientsDosage (mg / day)Indole-3-carbinol100Genistein from soy isoflavones45Lignans from Flaxseed (Linulife)20Pomegranate Extract40Broccoli Powder200

[0050]Generally, a dry powder formulation is prepared by placing the specified amounts of each ingredient in a V-Blender. The ingredients are mixed and pulverized until a granular mixture is obtained. The dry powder formulation can then be formed in several specific processes for producing various typical oral dosage forms as known by those of ordinary skill in the art. The powdered forms may then be either compressed into tablets and coated, or filled into gelatin capsu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diphenolic structureaaaaaaaaaa
structureaaaaaaaaaa
compositionsaaaaaaaaaa
Login to View More

Abstract

Methods for controlling estrogen metabolite formation in a subject and compositions for use therein are disclosed and described. In one aspect, estrogen metabolite formation may be controlled by coadministering an effective amount of a phytoestrogen and an indole compound.

Description

[0001]This application is a continuation of U.S. patent application Ser. No. 12 / 191,378 filed on Aug. 14, 2008, which is a continuation of U.S. patent application Ser. No. 11 / 334,768, filed on Jan. 17, 2006, which is a continuation of U.S. patent application Ser. No. 11 / 255,169, filed on Oct. 19, 2005, which claims the benefit of U.S. Provisional Patent Application Ser. No. 60 / 622,344 filed on Oct. 25, 2004, each of which is incorporated herein by reference in their entirety.THE FIELD OF THE INVENTION[0002]This invention relates to compositions and methods for administration of phytoestrogens to women. Accordingly, the invention involves the fields of botany, nutritional and health sciences and medicine.BACKGROUND OF THE INVENTION[0003]Many women have a difficult time managing the effects of hormonal changes that accompany the aging body. Many women suffer from known hormonal conditions and symptoms as a result of hormonal imbalances or deficiencies, such as, menopause, endometriosi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/404A61K31/353
CPCA61K31/353A61K31/404A61K31/352
Inventor BLACKNER, LORI
Owner NSE PROD INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com